Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The Ontario Cancer Treatment Practice Guidelines Initiative

M Levine1, G Browman, T Newman

  • 1Ontario Cancer Treatment and Research Foundation, Hamilton Regional Cancer Centre.

Oncology (Williston Park, N.Y.)
|November 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

O. Harold Warwick: Canada's first medical oncologist.

Current oncology (Toronto, Ont.)·2011
Same author

Cell-cycle characteristics - alterable determinants of remission duration in a study of 179 standard risk newly diagnosed patients with acute myeloid-leukemia.

International journal of oncology·2011
Same author

Vera Peters and the conservative management of early-stage breast cancer.

Current oncology (Toronto, Ont.)·2010
Same author

Vera Peters and the curability of Hodgkin disease.

Current oncology (Toronto, Ont.)·2008
Same author

Promoting best gynecologic oncology practice: a role for the Society of Gynecologic Oncologists of Canada.

Current oncology (Toronto, Ont.)·2007
Same author

Use of systemic therapy in women with recurrent ovarian cancer--development of a national clinical practice guideline.

Gynecologic oncology·2007
Same journal

Emerging T-Cell Engagers and Novel Immunotargets in Multiple Myeloma.

Oncology (Williston Park, N.Y.)·2026
Same journal

Access to Care and the Affordable Care Act: Why Do Problems Exist 15 Years Later?

Oncology (Williston Park, N.Y.)·2026
Same journal

Synchronous Endometrial and Ovarian Cancers: A Case Study and Literature Review.

Oncology (Williston Park, N.Y.)·2026
Same journal

Perceived Social Support, Anxiety, and Depression Among Women With Breast Cancer.

Oncology (Williston Park, N.Y.)·2026
Same journal

Before Certainty.

Oncology (Williston Park, N.Y.)·2026
Same journal

Adult T-Cell Leukemia/Lymphoma and Epstein-Barr Virus-Positive DLBCL: A Rare Concomitant Association.

Oncology (Williston Park, N.Y.)·2026
See all related articles

The Ontario Cancer Treatment Practice Guidelines Initiative developed a structured approach for creating evidence-based cancer treatment guidelines. This process involves site groups, a methods framework, and community practitioner feedback for guideline refinement.

Area of Science:

  • Oncology
  • Health Services Research
  • Clinical Practice Guidelines

Background:

  • Established in 1993, the Ontario Cancer Treatment Practice Guidelines Initiative aimed to standardize cancer care.
  • A structured organizational framework was implemented, including a coordinating committee, methods resource group, and disease site groups.

Purpose of the Study:

  • To describe the organizational structure and methodology used for developing cancer treatment practice guidelines in Ontario.
  • To outline the process of guideline formulation, incorporating evidence and practitioner feedback.

Main Methods:

  • Utilized a practice guidelines development cycle, a methodologic framework employed by 10 provincial site groups.
  • Incorporated a feedback loop where preliminary recommendations were shared with community practitioners for input and modification.

Related Experiment Videos

Main Results:

  • Successfully established a systematic process for developing evidence-based cancer treatment guidelines.
  • Produced practice guidelines through a collaborative approach involving expert groups and community practitioners.

Conclusions:

  • The initiative established a robust framework for guideline development.
  • Further research is needed to optimize guideline dissemination and evaluate their impact on cancer treatment practices.